Table 2 Short- and medium-term outcomes

Primary endpoint

(Death and/or hospitalisation)

5/70 (7.1)

13/71 (18.3)

Secondary endpoint

(Death and/or non-fatal stroke)

2/71 (2.8)

6/71 (8.5)

All-cause mortality

2/71 (2.8)

6/71 (8.5)

Non-fatal complications

(n = 69)

(n = 65)

 All-cause hospitalisation

5/69 (7.2)

9/65 (13.8)

 Valve-related hospitalisation

3/69 (4.3)

2/65 (6.2)

 Non-fatal stroke

0/69 (0.0)

0/62 (0.0)

 Acute kidney injury (stage 2 or 3)

3/69 (4.3)

5/64 (7.8)

 Major vascular complication

1/69 (1.4)

0/64 (3.1)

 Repeat procedure for valve dysfunction

0/69 (0)

1/62 (1.6)

 Myocardial infarction

0/69 (0)

0/62 (0)

 PPI

9/69 (13.0)

9/65 (13.8)